In summary, patients with the chronic fatigue syndrome show impaired capacity for exercise despite an increased perception of their exertion. We found no evidence for a deficient cardiovascular response or peripheral muscle function other than that which would be expected as a result of deconditioning. Other mechanisms, however, such as atrophy of muscle fibre or depletion of muscle enzymes may result in similar findings and merit further invesfigation.
Abstract
Objective-To identify measures of immune state that reflect the course ofHIV related disease in order to predict deterioration of symptoms and assess response to treatment.
Design-Five year longitudinal clinical and laboratory study.
Setting-Regional haemophilia centre, university virology laboratory, and Medical Research Council laboratory.
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predictive value of the measurement in the asymptomatic stage is doubtful from this study as only two patients in our group with symptoms had an increased plasma neopterin concentration a year or more before onset of CDC category IV disease. IgA -The mean plasma IgA concentration started to increase three years after seroconversion (fig 4c) , and this shift was almost entirely attributable to the subgroup with symptoms. Analysis of patterns in individual patients, however, showed that the trend was not consistent. Three of the patients with symptoms showed no convincing rise in IgA concentration, and in all patients in whom the rise was unequivocal (reaching ¢i5 g/l) this happened only after symptomatic disease was recognised. Two of the patients with HIV antibody without symptoms had IgA concentrations >5 g/l. In one patient this progressed, but in the other, whose IgA concentration before infection was 4 75 g/l, only the latest (1989) value was above that (5-4g/1). Two members of the subgroup without HIV antibody had repeated (but not rising) values marginally above 5g/l.
Cell mediated immunity-Skin test delayed hypersensitivity responses on initial examination in 1984-5 were depressed in all members of the cohort compared with those in healthy age matched subjects (fig 5) . Repeat testing in 1987-8 (in all patients except one in the group positive for HIV antibody) showed a further decline in the subgroup with HIV antibody, which is now distinguishable from the subgroup without antibody. The overall response was so low that no correlation was evident with clinical state in individual patients positive for HIV antibody.
Discussion
Although immunological abnormalities in patients with haemophilia A are well recognised without HIV infection,'67 information from this uniquely homogeneous cohort is of special value because its members were assessed immunologically before exposure to HIV and have participated in detailed follow up studies at regular intervals. It has thus been possible to record changes in those measures of immune state that have been proposed as markers for HIV related disease and to establish how well or otherwise they correlate with clinical disease progression. This is important not only for understanding of the immunopathogenesis of AIDS but, more specifically, for identifying variables that may be used to assess response when treatment is introduced before symptoms are expressed. Our previous studies identified the HLA haplotype Al B8 DR3 as a predictor of rapid progression to symptomatic disease after infection with HIV-I,'8 and this was later corroborated in the American multicentre AIDS cohort study'9 and in an Australian report. 20 We also showed that the presence of circulating p24 antigen and successful isolation of the virus from cultured blood lymphocytes correlate with the development of HIV related symptoms in this cohort. ' Conclusions-Discrimination against ethnic minorities occurs in the competition for training posts among graduates from British medical schools. There was no evidence of discrimination against women graduates. Shortlisting procedures based on objective scoring systems may help to ensure equality of opportunity in future.
Introduction
Several lines of evidence suggest that discrimination against women and ethnic minorities occurs in British medicine. 2 Systematic discrimination has been recorded in the admissions procedure of at least one medical school,3 and analysis of the proportions of students at other medical schools who had nonEuropean names suggests that this was not an isolated instance.' The only available data on the career patterns of British trained doctors from ethnic minorities are from a survey of hospital doctors in two northern regions in 1980. 4 The results suggested that doctors from ethnic minorities, whether trained in Britain or overseas, were experiencing disproportionate difficulty in obtaining hospital posts compared with their native European counterparts. The survey, however, was not based on a representative sample of medical graduates, and the number of British trained doctors from ethnic minorities was very small. In 1987 the University Hospitals Association decided to undertake a survey of the careers of recent medical graduates to examine the problems experienced by this group in obtaining suitable training posts and pursuing their chosen careers.5 We examined this dataset for evidence of discrimination by sex and race.
Methods
Five medical schools were chosen to make up a geographically representative sample. Questionnaires were sent during 1987 to all 2002 medical graduates who qualified during 1981, 1983 , and 1985 at these five medical schools accompanied by a covering letter from the dean ofeach graduate's medical school. To maintain confidentiality questionnaires were identified only by serial number. Linkage to names and addresses was used only to identify non-respondents, who were sent a reminder letter. A total of 1572 replies were received, giving a response rate of 79%.
The questionnaire included items on demographic background, career choice, and intended postgraduate qualifications at the time of completing the preregistration year; numbers of unsuccessful applications submitted before obtaining each senior house officer and registrar post; numbers of interviews for each post without the offer of a job; and present career choice. Those who had changed their first choice of career since completing the preregistration year were asked to BMJ VOLUME 301
